A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health
City of Hope Medical Center
NYU Langone Health